Schaeffer's Top Stock Picks for '25

Analyst: Positive Catalysts Can't Save This Pharma Stock

Struggling BMY is a price-target cut risk going forward

Deputy Editor
Feb 6, 2024 at 9:00 AM
facebook X logo linkedin


Biopharmaceutical stock Bristol-Myers Squibb Co (NYSE:BMY) is in focus this morning, after a downgrade to "neutral" from "buy" at Redburn-Atlantic. The analyst in coverage also lowered its price target to $54 from $77 -- still a 12.6% premium to last night's close at $47.98. BMY is fractionally lower before the open.

The Wall Street analyst cited concerns regarding Bristol-Myers Squibb's product pipeline and market challenges. It argued that any positive impact from the company's recent acquisitions won't be enough to overcome headwinds against its key products.

Leerink Partners and Morgan Stanley yesterday cut their price targets on BMY, yet the average 12-month target price of $58.20 is still a 21.3% premium to last night's close, indicative that more bear notes could be on the way.

Bristol-Myers Squibb stock is underperforming the broader market, down 6.5% in 2024 versus the SPDR S&P 500 ETF Trust's (SPY) 3.6% year-to-date lead. The equity is down 35.6% over the last 12 months, and just yesterday fell to a nearly four-year low of $47.68.

Short-term options traders are also more pessimistic than usual. This is per BMY's Schaeffer's put/call open interest ratio (SOIR) of 0.73 that ranks higher than 92% of readings from the past 12 months.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?